Thụy Điển -
Tiếng Thụy Điển -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone neutec 50 mikrogram/250 mikrogram/dos inhalationspulver, avdelad dos
neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/250 mikrogram/dos - salmeterolxinafoat 73 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans; laktosmonohydrat hjälpämne
Thụy Điển -
Tiếng Thụy Điển -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone neutec 50 mikrogram/100 mikrogram/dos inhalationspulver, avdelad dos
neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/100 mikrogram/dos - laktosmonohydrat hjälpämne; salmeterolxinafoat 73 mikrog aktiv substans; flutikasonpropionat 100 mikrog aktiv substans
Thụy Điển -
Tiếng Thụy Điển -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone neutec 50 mikrogram/500 mikrogram/dos inhalationspulver, avdelad dos
neutec lnhaler lreland limited - flutikasonpropionat; salmeterolxinafoat - inhalationspulver, avdelad dos - 50 mikrogram/500 mikrogram/dos - salmeterolxinafoat 73 mikrog aktiv substans; laktosmonohydrat hjälpämne; flutikasonpropionat 500 mikrog aktiv substans
Liên Minh Châu Âu -
Tiếng Thụy Điển -
EMA (European Medicines Agency)
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - läkemedel mot obstruktiv lungsjukdom, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Liên Minh Châu Âu -
Tiếng Thụy Điển -
EMA (European Medicines Agency)
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Liên Minh Châu Âu -
Tiếng Thụy Điển -
EMA (European Medicines Agency)
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
Liên Minh Châu Âu -
Tiếng Thụy Điển -
EMA (European Medicines Agency)
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.